What Happened?
Cambridge, MA-based Ring Therapeutics Appointed Konstantin Konstantinov as Chief Technology Officer
About the Company
Ring`s research team has uncovered the world`s largest collection of commensal anelloviruses and are harnessing these natural viruses to target a wide array of diseases with significant unmet need. The unique biology of anelloviruses provides a foundation for a revolutionary new platform and a new class of programmable medicines.
About the Person
Konstantin Konstantinov is Chief Technology Officer at Ring Therapeutics. Previously, Konstantin held various senior IT leadership roles in the industry.
Info Source
News
Short Profile